UCM-037

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameUCM-037
Drug Alias Nameanti-angiogenic compounds (Universidad Complutense de Madrid/Consejo Superior De Investigaciones Cientificas)UCM-037
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsFibroblast growth factor receptors antagonists
TargetsFibroblast growth factor receptorsVascular endothelial growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLa Universidad Complutense de Madrid
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSpanish National Research CouncilLa Universidad Complutense de Madrid
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A